RGEDF
Price
$27.17
Change
+$2.26 (+9.07%)
Updated
Jul 19 closing price
Capitalization
5.69B
SGIOF
Price
$19.00
Change
+$2.21 (+13.16%)
Updated
Aug 15 closing price
Capitalization
15.19B
Interact to see
Advertisement

RGEDF vs SGIOF

Header iconRGEDF vs SGIOF Comparison
Open Charts RGEDF vs SGIOFBanner chart's image
Gedeon Richter
Price$27.17
Change+$2.26 (+9.07%)
Volume$3
Capitalization5.69B
Shionogi & Co
Price$19.00
Change+$2.21 (+13.16%)
Volume$800
Capitalization15.19B
RGEDF vs SGIOF Comparison Chart in %
Loading...
SGIOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RGEDF vs. SGIOF commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGEDF is a Hold and SGIOF is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 18, 2025
Stock price -- (RGEDF: $27.17 vs. SGIOF: $19.00)
Brand notoriety: RGEDF and SGIOF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: RGEDF: 100% vs. SGIOF: 77%
Market capitalization -- RGEDF: $5.69B vs. SGIOF: $15.19B
RGEDF [@Pharmaceuticals: Generic] is valued at $5.69B. SGIOF’s [@Pharmaceuticals: Generic] market capitalization is $15.19B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.3B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RGEDF’s FA Score shows that 1 FA rating(s) are green whileSGIOF’s FA Score has 3 green FA rating(s).

  • RGEDF’s FA Score: 1 green, 4 red.
  • SGIOF’s FA Score: 3 green, 2 red.
According to our system of comparison, SGIOF is a better buy in the long-term than RGEDF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SGIOF’s TA Score shows that 6 TA indicator(s) are bullish.

  • SGIOF’s TA Score: 6 bullish, 2 bearish.

Price Growth

RGEDF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while SGIOF (@Pharmaceuticals: Generic) price change was +13.16% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +6.26%. For the same industry, the average monthly price growth was +68.76%, and the average quarterly price growth was +80.82%.

Industries' Descriptions

@Pharmaceuticals: Generic (+6.26% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SGIOF($15.2B) has a higher market cap than RGEDF($5.69B). SGIOF has higher P/E ratio than RGEDF: SGIOF (13.96) vs RGEDF (7.99). SGIOF YTD gains are higher at: 55.610 vs. RGEDF (0.000). RGEDF has higher annual earnings (EBITDA): 374B vs. SGIOF (206B). SGIOF has more cash in the bank: 576B vs. RGEDF (202B). SGIOF has less debt than RGEDF: SGIOF (11.7B) vs RGEDF (21.3B). RGEDF has higher revenues than SGIOF: RGEDF (878B) vs SGIOF (419B).
RGEDFSGIOFRGEDF / SGIOF
Capitalization5.69B15.2B37%
EBITDA374B206B182%
Gain YTD0.00055.610-
P/E Ratio7.9913.9657%
Revenue878B419B210%
Total Cash202B576B35%
Total Debt21.3B11.7B182%
FUNDAMENTALS RATINGS
RGEDF vs SGIOF: Fundamental Ratings
RGEDF
SGIOF
OUTLOOK RATING
1..100
3422
VALUATION
overvalued / fair valued / undervalued
1..100
3
Undervalued
23
Undervalued
PROFIT vs RISK RATING
1..100
74100
SMR RATING
1..100
472
PRICE GROWTH RATING
1..100
7048
P/E GROWTH RATING
1..100
8729
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RGEDF's Valuation (3) in the null industry is in the same range as SGIOF (23). This means that RGEDF’s stock grew similarly to SGIOF’s over the last 12 months.

RGEDF's Profit vs Risk Rating (74) in the null industry is in the same range as SGIOF (100). This means that RGEDF’s stock grew similarly to SGIOF’s over the last 12 months.

SGIOF's SMR Rating (2) in the null industry is somewhat better than the same rating for RGEDF (47). This means that SGIOF’s stock grew somewhat faster than RGEDF’s over the last 12 months.

SGIOF's Price Growth Rating (48) in the null industry is in the same range as RGEDF (70). This means that SGIOF’s stock grew similarly to RGEDF’s over the last 12 months.

SGIOF's P/E Growth Rating (29) in the null industry is somewhat better than the same rating for RGEDF (87). This means that SGIOF’s stock grew somewhat faster than RGEDF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RGEDFSGIOF
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
57%
Stochastic
ODDS (%)
N/A
Bullish Trend 3 days ago
53%
Momentum
ODDS (%)
N/A
Bullish Trend 3 days ago
40%
MACD
ODDS (%)
N/A
Bullish Trend 3 days ago
58%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
23%
Bullish Trend 3 days ago
44%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
20%
Bullish Trend 3 days ago
51%
Advances
ODDS (%)
N/A
Bullish Trend 21 days ago
58%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
74%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
SGIOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OCCIN24.450.13
+0.53%
OFS Credit Company
PSO14.45-0.01
-0.08%
Pearson plc
MBAV10.52-0.01
-0.14%
M3 Brigade Acquisition V Corp.
NWBI12.02-0.16
-1.31%
Northwest Bancshares
VATE4.69-0.18
-3.70%
INNOVATE Corp

RGEDF and

Correlation & Price change

A.I.dvisor indicates that over the last year, RGEDF has been loosely correlated with PAIOF. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if RGEDF jumps, then PAIOF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGEDF
1D Price
Change %
RGEDF100%
N/A
PAIOF - RGEDF
33%
Loosely correlated
N/A
ASRT - RGEDF
31%
Poorly correlated
-0.64%
OILFF - RGEDF
11%
Poorly correlated
+0.26%
OWPC - RGEDF
4%
Poorly correlated
+25.00%
ROMJF - RGEDF
3%
Poorly correlated
-2.03%
More

SGIOF and

Correlation & Price change

A.I.dvisor tells us that SGIOF and ROMJF have been poorly correlated (+8% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SGIOF and ROMJF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGIOF
1D Price
Change %
SGIOF100%
+13.16%
ROMJF - SGIOF
8%
Poorly correlated
-2.03%
TEVJF - SGIOF
8%
Poorly correlated
N/A
SFOSF - SGIOF
6%
Poorly correlated
N/A
RGEDF - SGIOF
3%
Poorly correlated
N/A
PHCUF - SGIOF
-0%
Poorly correlated
N/A
More